Invention Publication
- Patent Title: ANTIBODY SPECIFIC TO SPIKE PROTEIN OF SARS-COV-2 AND USES THEREOF
-
Application No.: US18403419Application Date: 2024-01-03
-
Publication No.: US20240228591A1Publication Date: 2024-07-11
- Inventor: Kuo-I LIN , Che MA , Chi-Huey WONG , Szu-Wen WANG , Yi-Hsuan CHANG , Xiaorui CHEN , Han-Yi HUANG
- Applicant: ACADEMIA SINICA
- Applicant Address: TW Taipei
- Assignee: ACADEMIA SINICA
- Current Assignee: ACADEMIA SINICA
- Current Assignee Address: TW Taipei
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61K39/00 ; A61K39/42
Abstract:
The present disclosure relates to an antibody or antigen-binding fragment thereof that specifically binds to a spike protein of SARS-COV-2. The present disclosure also relates to a pharmaceutical composition, a method for treating and/or preventing diseases and/or disorders caused by a coronavirus in a subject in need thereof, and a method for detecting a coronavirus in a sample.
Public/Granted literature
- US12157763B2 Antibody specific to spike protein of SARS-CoV-2 and uses thereof Public/Granted day:2024-12-03
Information query
